LUGANO, Switzerland — Through a partnership with Alpen Group, Wana Brands is bringing its innovative all-natural line of popular cannabis-infused gummy products to Switzerland, which will serve as a launching pad for the rest of the European Union and beyond. The infused products company expects its gummies to launch in the Swiss market by 2025.

Last year, Switzerland’s health authority approved pilot trials involving the dispensing of cannabis for non-medicinal uses, effectively legalizing recreational cannabis in Europe for the first time. Spread throughout Switzerland, the pilot projects are intended to create a basis for future legal regulation. Wana Brands will offer the first U.S. cannabis edible gummy available in Switzerland through a partnership with Alpen Group, a vertically integrated cannabis platform.

“Since Wana Brands was established in Colorado’s budding market in 2010, our mission has been to pioneer our presence in emerging markets. This vision has now taken us across the Atlantic to Switzerland, marking 14 years of expansive growth. Our collaboration with Alpen Group, a company that mirrors our commitment to quality, positions us to become the pioneering American cannabis edibles brand in the European Union’s adult-use market,” said Nancy Whiteman, co-founder & CEO, Wana Brands. “Switzerland’s global acclaim for precision and excellence resonates with Wana’s core values. Through our alliance with Alpen, we’re leveraging world-class manufacturing standards.”

“Alpen Group is proud to join forces with the world-renowned cannabis edibles group, Wana Brands. As we embark on a journey of innovation and expansion, we look forward to serving as the epicenter of their global operations. From our headquarters in Lugano, Switzerland, we embrace the opportunity to fuse our strengths, expertise, and vision, propelling both entities toward unparalleled success. Together, we eagerly anticipate the collaborative effort, working hand in hand with Wana Brands’ esteemed team to realize their global aspirations and pioneer the future of the industry,” said Todd Boren, Co-founder and CEO of Alpen Group. “From a commercial standpoint, The distinct opportunities presented in possessing a unique arsenal of proprietary formulations provides us with a significant advantage, particularly in emerging markets. We look forward to working closely together on the legal recreational pilot programs underway in Switzerland.”

Safety and consistency are of chief importance. Switzerland has the most stringent manufacturing regulations in the world. Wana’s carefully formulated and innovative gummies will be produced in a 30,000 sq ft + GACP indoor, EU-GMP licensed facility, ensuring unmatched quality. With the precision of a Swiss watch, the Alpen Group invests in technology that prioritizes real-time data collection, rigorous testing, and adaptable design. Its internal traceability process monitors every step of production, adhering to the strictest levels of compliance and safety.

Through the partnership with The Alpen Group, Wana will be able to leverage innovative medical preparations and dosage formats. Wana’s product portfolio provides a range of different ratios and classes that enable customers to create the specific cannabis experience they want. Through Alpen, Wana will continue to guarantee the quality, consistency, and potency their customers have come to expect.

Wana Brands: Enhance Your Life

With North America’s largest distribution footprint, cannabis edibles producer Wana Brands is a top international brand available in 16 U.S. states, the U.S. territory of Puerto Rico and nine Canadian provinces and territories, generating close to $300 million in retail sales annually across more than 3,000 dispensaries. Through industry-leading innovation, Wana is developing cutting-edge use-case formulations and recipes, such as Wana Quick Fast-Acting Gummies, the top-selling quick-onset edible, and the Optimals Fast Asleep formulation. Wana is committed to the communities it serves by supporting more than 50 charitable organizations in the markets where the company operates. For more information, visit Subscribe to Wana’s e-newsletter. Follow Wana on Instagram, LinkedIn, and X.

About Alpen Group

Alpen Group is a leading pharmaceutical cannabis company headquartered in Switzerland, spearheading innovation in the global cannabis industry. With a distinguished partnership with a renowned 40-year-old pharmaceutical firm, we bring together unparalleled expertise and a vision for pioneering advancements. Drawing from 14 years of extensive experience in the US cannabis market, Alpen Group is dedicated to driving excellence in import/export, microbial remediation, manufacturing, and proprietary packaging solutions. Situated strategically in Switzerland, recognized as the pharmaceutical headquarters of the world, we are ideally positioned to capitalize on emerging opportunities and shape the future of adult-use regulatory frameworks in Europe. As pioneers in the field, we are committed to revolutionizing the cannabis landscape and delivering transformative solutions that enhance lives worldwide. For more information, please visit